Leading
Pharma Innovation
The Research Center Pharmaceutical Engineering (RCPE GmbH) is a globally recognized, independent and not-for-profit research company at the forefront of pharmaceutical process and product development.
We deliver innovative, tailor-made solutions for the pharmaceutical industry – covering everything from sophisticated in silico prediction and formulation to upscaling in our state-of-the-art pilot plant.
Our interdisciplinary team combines scientific and engineering expertise to accelerate the development and manufacturing of tomorrow’s medicines and improve the lives of patients worldwide.
Explore Our Core Competencies
RCPE develops next‑generation tools that help pharmaceutical companies rapidly design, formulate and manufacture better medicines for patients.
Next-Generation Manufacturing
RCPE Accelerates Pharmaceutical Progress
We help partners de‑risk development, shorten time‑to‑market and co‑create scalable solutions in joint projects, from feasibility studies to integrated industrial implementations.
With state‑of‑the‑art laboratories, a pilot plant and advanced simulation capabilities, RCPE offers partners an integrated environment to design, test and scale innovative medicines and production processes.
News and Press
- Media
Podcast Women4Innovation
29.06.2026 | ncp.ip | RCPE’s Caroline Schober joins the latest Women4Innovation podcast to discuss innovation at the intersection of applied research, industry, and entrepreneurship. Together with Prewave co-founder Lisa Smith, she shares insights into her career path and how innovation can create real-world impact.
- Media
AI, Physics & Reliable Pharmaceutical Processes
29.06.2026 | JUST Magazine | Artificial intelligence is transforming pharmaceutical engineering, but data alone is not always enough. RCPE expert Gert Breitfuss explains how combining AI with physics-based modelling can help make pharmaceutical processes more reliable and predictable.
- Media
Usability in Women’s Health
02.06.2026 | botenstoff | Personalized design and advanced manufacturing technologies are opening new possibilities in women’s health. Patient-specific pessaries are being developed to improve comfort, usability, and acceptance, supporting better outcomes and quality of life for women.
- Media
Advancing Pharma Manufacturing in Europe
26.05.2026 | ORF | In an interview with ORF Steiermark, Johannes Khinast spoke about the growing need for stronger and more independent pharmaceutical manufacturing capabilities in Europe, and how innovation in continuous manufacturing can contribute to that goal.
Events
- 04-05
- Mar
AATM 2027
Accelerating Access to Medicines (AATM) is an international forum organized by RCPE, bringing together experts from industry, academia, regulatory agencies, and healthcare. The event focuses on interdisciplinary exchange, innovative approaches, and strategic partnerships to accelerate pharmaceutical development and improve access to medicines.
Our Shareholders
RCPE’s ownership structure is unique: we are a private, non-profit company jointly owned by Graz University of Technology (49%), the University of Graz (36%), and the non-university, public research organization Joanneum Research GmbH (15%). This ensures our complete independence from the pharmaceutical industry and positions us as a neutral, publicly owned research organization.
Our Public Funding Partners
RCPE is funded under the COMET Program (Competence Centers for Excellent Technologies), an Austrian flagship initiative designed to promote outstanding, application-oriented research and development in key technology areas. The COMET Program is jointly funded by the Austrian federal government, the federal states, participating companies, and research organizations.
Curious how RCPE can strengthen your pharmaceutical pipeline?
Reach out to RCPE to find the right collaboration model for your development and manufacturing needs.